Screening Mammography Guidance for COVID-19 Vaccine Related Adenopathies
Graybill Radiology Department would like to share the following regarding screening mammography and recently published recommendations for best management during the pandemic.
In response to evidence published last week in Clinical Imaging that the two approved COVID-19 vaccines (Pfizer & Moderna) can potentially lead to axillary adenopathies that can mimic breast malignancies.
Moving forward our Radiology Department will advise all patients scheduling screening mammograms of the following recommendation by the Society of Breast Imaging.
“When possible – being sure not to unduly delay care – schedule screening exams before the first vaccine dose or four-to-six weeks after the second dose.” – SBI 1/26/21
Radiology services are available onsite at our Escondido Second Avenue and Fallbrook Offices. Our certified radiology technicians are trained in anatomy, patient positioning, equipment protocols, radiation safety and protection, and basic patient care.
Services include: diagnostic radiology, ultrasound, mammography, and bone density testing.